• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON & JOHNSON VISION CARE, INC. ¿ US ACUVUE OASYS; LENSES, SOFT CONTACT, EXTENDED WEAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON & JOHNSON VISION CARE, INC. ¿ US ACUVUE OASYS; LENSES, SOFT CONTACT, EXTENDED WEAR Back to Search Results
Catalog Number PH
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abscess (1690); Bacterial Infection (1735); Burning Sensation (2146); Discomfort (2330)
Event Date 11/14/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).Initial reporter¿s phone number: (b)(6).
 
Event Description
On 21nov2019 a call was received from a patient¿s (pt) family member in argentina who reported the pt had an ¿eye bacteria¿ (affected eye not provided) caused by the acuvue® oasys® brand contact lens.The pt went to the emergency room yesterday, (b)(6) 2019.No additional information was provided.On 21nov2019 additional information was provided: the pt wanted provide information as the ¿lens produced abscess¿ in the eye.On 21nov2019 a call was placed to the pt who provided additional information: the pt reported od discomfort and burning sensation on (b)(6) 2019 which continued after removing the suspect lens.The pt went to an urgent care and then was transferred to another eye center due to ¿severity of eye.¿ the diagnosis was not provided.The pt was prescribed vigamox eye drops every 2 hours, eritromed (erythromycin) eye drops every 2 hours for 1 week and artelac (lubricating eye drops) for dryness as needed.The pt had a follow-up visit on (b)(6) 2019 and the medications were changed to vigamox tid for 7 days and lopred tid for 7 days.The pt stated after the 7 days of tid eye drops, the eye drops of vigamox and lopred were decreased to bid for 7 days.The pt has a return visit with the eye care provider (ecp) scheduled for (b)(6) 2019.The pt reported the od is feeling better.The pt has a 2-week replacement schedule with daily lens wear.The pt uses opti-free pure moist solution and arlyt solution to clean and store the lenses.The pt¿s medical records were requested.The pt will pick up the medical records from the ecp on (b)(6) 2019 and will send the records by email.Multiple calls were placed to the pt for additional medical information, but nothing additional has been received.Multiple calls were placed to the pts treating ecp for additional medical information.Nothing additional has been provided.This od event is being reported as a worst-case event as we were unable to verify the pts diagnosis and treatment with the treating ecp.The suspect od contact lens was requested for return for evaluation, but it has not been received.A lot history review was performed and revealed the following: the batch record did not show any abnormalities in monomer and solution testing.All parameters tested were within specification.All sterilization requirements were successfully completed.Lot b00s8j2 was produced under normal conditions.If any further relevant information is received, a supplemental report will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACUVUE OASYS
Type of Device
LENSES, SOFT CONTACT, EXTENDED WEAR
Manufacturer (Section D)
JOHNSON & JOHNSON VISION CARE, INC. ¿ US
7500 centurion parkway
jacksonville FL
Manufacturer Contact
rose harrell
7500 centurion parkway
jacksonville, FL 32256
9044433364
MDR Report Key9454240
MDR Text Key185043708
Report Number1057985-2019-00142
Device Sequence Number1
Product Code LPM
Combination Product (y/n)Y
Reporter Country CodeAR
PMA/PMN Number
P040045
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign
Reporter Occupation Other
Type of Report Initial
Report Date 11/21/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/11/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date04/01/2024
Device Catalogue NumberPH
Device Lot NumberB00S8J2
Was Device Available for Evaluation? No
Date Manufacturer Received11/21/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/08/2019
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age34
-
-